OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spliced X‐box binding protein 1 induces liver cancer cell death via activating the Mst1‐JNK‐mROS signalling pathway
Jie Song, Wei Zhao, Chang Lu, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 12, pp. 9378-9387
Closed Access | Times Cited: 8

Showing 8 citing articles:

Spliced or Unspliced, That Is the Question: The Biological Roles of XBP1 Isoforms in Pathophysiology
Xinxin Luo, Leader Alfason, Mankun Wei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2746-2746
Open Access | Times Cited: 30

ALKBH5‐Mediated m6A Modification of XBP1 Facilitates NSCLC Progression Through the IL‐6–JAK–STAT3 Pathway
Hengxing Liang, Chunmin Zhang, Minxin Hu, et al.
Molecular Carcinogenesis (2024)
Open Access | Times Cited: 2

Identification of key genes associated with esophageal adenocarcinoma based on bioinformatics analysis
Weifeng Qi, Rongyang Li, Lin Li, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 23, pp. 1711-1711
Open Access | Times Cited: 7

Targeting X box-binding protein-1 (XBP1) enhances the sensitivity of HOS osteosarcoma cells to pyropheophorbide- α methyl ester-mediated photodynamic therapy
Haoyang Yu, Ye Zhang, Qiang Zuo, et al.
Photodiagnosis and Photodynamic Therapy (2021) Vol. 37, pp. 102646-102646
Open Access | Times Cited: 4

Concomitant administration of lenvatinib and camrelizumab for the treatment of hepatocellular carcinoma, and its effect on hepatocellular carcinoma control
Ruibao Liu, Xiaolei Zhang, Xing Wang
Tropical Journal of Pharmaceutical Research (2022) Vol. 21, Iss. 9, pp. 1973-1978
Open Access | Times Cited: 1

XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma
Zahra Hendi, Pedram Asadi Sarabi, David C. Hay, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 12, pp. 1207-1215
Closed Access

Page 1

Scroll to top